AscendiantLogo Better

Ascendiant Capital Markets, LLC

Ascendiant News

See Our Impact

Need capital to meet your growth plans? Get in touch with our team today!

Ascendiant Serves as Sole M&A Advisor on PAVmed, Inc.’s Acquisition of CapNostics, LLC

 JUPITER, Florida — October 11, 2021 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the completion of a definitive purchase agreement between PAVmed, Inc. (Nasdaq: PAVM) of New York, New York, and CapNostics, LLC of Concord, North Carolina.  For a copy of the announcement, please click here.

Share this post with your friends:

Facebook
Twitter
LinkedIn

Want to stay up-to-date with the latest at Ascendiant? Subscribe to our mailing list!

See other recent news

July 6, 2022
Ascendiant Serves as Sole M&A Advisor on SINTX Technologies, Inc.’s (Nasdaq: SINT) Acquisition of Technology Assessment & Transfer, Inc. (TA&T)
June 27, 2022
Ascendiant Initiates Research Coverage on Blackboxstocks Inc. (Nasdaq: BLBX)
June 23, 2022
Ascendiant Capital Markets LLC serves as Sole M&A Advisor on Sale of Pinnacle Precision to The Partner Companies
June 15, 2022
Ascendiant Capital Markets LLC serves as Sole Sales Agent on $46,400,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc.’s Series D Preferred Stock (NYSE American: NILE PRD)
May 31, 2022
Ascendiant Serves as Sole Placement Agent on $6,015,000 Private Placement for Nemaura Medical, Inc. (Nasdaq: NMRD), Increases Total Amount to $36,045,000 over Three Transactions
April 7, 2022
Ascendiant Serves as Financial Advisor on $50,000,000 Registered Direct for PAVmed Inc. (Nasdaq: PAVM)
April 4, 2022
Ascendiant Serves as Sole Sales Agent on $9,360,000 At-The-Market (ATM) Offering for ENDRA Life Sciences, Inc. (Nasdaq: NDRA)
March 10, 2022
Ascendiant Serves as Sole Placement Agent on $10,700,000 Private Placement for Intrusion, Inc. (Nasdaq: INTZ)
February 28, 2022
Ascendiant Serves as Sole Sales Agent on $200,000,000 At-the-Market (ATM) Offering for BitNile Holdings, Inc. (NYSE American: NILE)
January 24, 2022
Ascendiant Initiates Research Coverage on SurgePays, Inc. (Nasdaq: SURG)
January 11, 2022
Ascendiant Serves as Placement Agent on $13,700,000 Public Offering for EVmo, Inc.
December 26, 2021
Ascendiant Initiates Research Coverage on Lucid Diagnostics, Inc. (Nasdaq: LUCD)